Driving innovation in healthcare
Shaping the Future of Molecular Diagnostics in India
India’s molecular diagnostics sector is experiencing significant growth, driven by rapid innovation in testing technologies and increasing investments from venture capitalists. In 2024, the Indian molecular diagnostics market was valued at approximately $1.3 billion. It is projected to nearly double to around $2.7 billion by 2033, reflecting an annual growth rate of about 7–8%.
Coimbatore Kidney Care and Research Limited (CKC) has long been a pioneer in laboratory diagnostics in the region, having established Medserve Labs in 1980—one of Coimbatore’s earliest diagnostic facilities. Recognizing the growing need for rapid and precise testing, CKC has now taken a significant step forward by launching the Coimbatore Molecular Diagnostic Laboratory (CMDL). With state-of-the-art infrastructure, rapid turnaround, and rigorous quality protocols, CMDL empowers physicians, oncologists, and transplant specialists with high-sensitivity, clinically relevant insights for accurate diagnosis, risk assessment, and treatment planning. As part of CKCRL’s integrated healthcare ecosystem, CMDL is a trusted partner for hospitals, clinics, and specialists across South India thus, marking a transformative leap in the region’s healthcare infrastructure.
Closing Critical Diagnostic Gaps
Advanced Molecular Testing with Standard of Care Technologies
CMDL is an advanced clinical laboratory designed to bridge critical diagnostic gaps by offering a comprehensive suite of high-complexity molecular clinical diagnostic tests. We specialize in advanced testing for infectious diseases, genetic disorders, cancer markers, and transplant immunology. By bringing cutting-edge technologies like Massively Parallel Sequencing (NGS), conventional and real-time PCR, Capillary Electrophoresis, Luminex, Cytogenetics, and reverse hybridization technologies closer to patients, we enable faster diagnosis, personalized treatment, and reduce the dependence on distant referral labs, addressing rising healthcare demands and the scarcity of specialized tests in the region.
What Sets CMDL Apart
Precision in Every Test
Q-PCR powered accuracy ensures dependable outcomes
Rapid Turnaround Times
Fast reporting empowers timely clinical decisions
Comprehensive Diagnostics
Wide test menu covering infections, genetics, and oncology
Trusted Clinical Expertise
Backed by CKC’s legacy of healthcare excellence